Woman of the Week: Janssen's Dr. Sylvie Laquerre

Why following the science is crucial when bringing new compounds to market.  

By Taren Grom • Jan. 26, 2022

How AI is helping pharma solve some of its COVID problems

With the pressure still on pharma to innovate quickly and go digital, the use-cases for AI are increasing in stride.

By Meagan Parrish • Jan. 25, 2022

Explore the Trendline➔

Oncology R&D

Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.   

By PharmaVoice staff

One man's quest to boost the patient's role in clinical trials

How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.

By Robin Robinson • Jan. 24, 2022

Leaders predict improving patient engagement will lead to growth opportunities

Why patient engagement is key to successful business growth.

By Taren Grom • Jan. 24, 2022

Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

By Alexandra Pecci • Jan. 23, 2022

Vaxxinity looks to pioneer the next revolution in pharma

With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

By Meagan Parrish • Jan. 14, 2022

Pharma execs reveal the industry's most pressing issues

Several market factors — including COVID — are driving changes and trends in the industry.

By Taren Grom • Jan. 14, 2022

Welcome to the new PharmaVoice

A similar mission, a new format, and our plans for PharmaVoice's next chapter.

By Davide Savenije • Jan. 13, 2022

5 trends shaping clinical trial regulations in 2022

As agencies respond to innovations in pharma, notable shifts in 2022 are on the way.

By Meagan Parrish • Jan. 11, 2022

Ovid's CEO shares his vision for rare disease developments

Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

By Kim Ribbink • Jan. 10, 2022

Australian firefighters raise funds for ALS research

Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS. 

By Kim Ribbink • Jan. 5, 2022

Rare disease innovation in 2022

More companies are targeting gene therapies for rare disease treatments.

By Kim Ribbink • Jan. 5, 2022

Speak Out: The Value of Using Neutral Analysis in Life Sciences Disputes

Imagine that you have multiple published and peer-reviewed clinical trials and time is of the essence to get your vaccine to market. Unfortunately, you are involved in a lawsuit for patent infringement with a competitor. Will you go to trial? What are your odds of prevailing? HAVE THE RIGHT ST...

By Hon. Gregory M. Sleet (Ret.) • Nov. 15, 2021

Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli

The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...

By Clark Wooten • Nov. 15, 2021

Letter from the Editor

Igniting Innovation Innovation is a tricky thing to define as it means different things to different people and organizations. For example, Mike Rea, CEO and founder of IDEA Pharma, believes the most important observation is separating invention from innovation. “Innovation is the recognition of ...

By Taren Grom • Oct. 1, 2021

Upfront

Pharma Collaborators Launch Initiative to Improve Patients’ Adherence to Humira AbbVie GK, Eisai Co., and EA Pharma Co. have teamed up to launch the Humira Support Tool Ordering Service for Patients, an initiative intended to improve patients’ adherence to Humira therapy in Japan. The support too...

By PharmaVoice Team • Oct. 1, 2021

The Innovators' Roundtable

We tapped into innovators from around the industry to discover how they view this hot topic and what innovation means to them. Innovation means different things to different people. Sometimes it’s a big leap and sometimes it means iterative changes to a process that lead to a big impact. Defining...

By Taren Grom • Oct. 1, 2021

Three Steps to Innovate Patient Solutions

At the heart of all of our work is meeting patient needs, so let’s take a deep dive into all of the routes currently available to deliver patient solutions. The challenge is to balance the conversation between pragmatism and idealism. To call out the elephant in the room, there’s a big appetite f...

By Corina Kellam • Oct. 1, 2021

Synthetic Control Arms: A Broader Clinical reach

Amid the skyrocketing cost of clinical trials, the increase in collection and use of digital data, and the FDA’s commitment to considering real-world data (RWD) in its regulatory process, a growing number of life-sciences companies are looking at and employing external or synthetic control arms. ...

By Carolyn Gretton • Oct. 1, 2021

Executive Perspective: A Bold Precision Medicine Ambition: Breaking Down Barriers to Revolutionize Cancer care

A Conversation with Omar Perez, Ph.D. As a scientist, Omar Perez, Ph.D., has always been fascinated with precision medicine and targeted therapies. “This interest originated during my graduate school days when I was trying to tease apart how the immune cell system interacts," he says. “From this ...

By Omar Perez • Oct. 1, 2021

Does Your Agency Partner Have an Innovation Lab? It Should.

Times change. It’s cliché to say it, I know, but it really is one of the few constants in the universe. Yet many agencies still struggle with this truth. Of course, it’s easy to get caught up in the day-to-day routine of agency life. Everything just cruising along, no insurmountable bumps, nothin...

By Carmine Jichetti • Sept. 1, 2021

3 Ways to Better Enable your MSLs: The Case for Context

Like every other stakeholder in the healthcare system, medical science liaisons (MSLs) faced upheaval related to the COVID-19 pandemic. As medical practices pivoted to telehealth, MSLs shifted from in-person interactions to virtual sessions with thought leaders (TL). For their commitment and resi...

By Jennifer Millard • Sept. 1, 2021

PharmaVoice 100 Who's on the List – By Category

Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

By PharmaVoice Team • Aug. 1, 2021

Clinical Experts

These clinical development experts are redefining clinical operations to increase efficiencies, reduce costs and timelines, and improve the safety profiles of bringing new medicines to patients. Unwavering determination to further clinical research Igniting change by… ensuring cross...

By PharmaVoice Team • Aug. 1, 2021

Letter from the Editor

The clinical trial horizon The rise of decentralized clinical trials, otherwise known as DCTs, is the hottest topic in the clinical research arena at the moment, and appropriately so. The global pandemic exposed significant cracks in the structure of how clinical trials have been conducted for de...

By Taren Grom • June 1, 2021